New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis

Mario Sabatelli, Giuseppe Marangi, Amelia Conte, Giorgio Tasca, Marcella Zollino, Serena Lattante

Research output: Contribution to journalArticle

Abstract

Amyotrophic Lateral Sclerosis (ALS) is characterized by the degeneration of upper and lower motor neurons. Clinical heterogeneity is a well-recognized feature of the disease as age of onset, site of onset and the duration of the disease can vary greatly among patients. A number of genes have been identified and associated to familial and sporadic forms of ALS but the majority of cases remains still unexplained. Recent breakthrough discoveries have demonstrated that clinical manifestations associated with ALS-related genes are not circumscribed to motor neurons involvement. In this view, ALS appears to be linked to different conditions over a continuum or spectrum in which overlapping phenotypes may be identified. In this review, we aim to examine the increasing number of spectra, including ALS/Frontotemporal Dementia and ALS/Myopathies spectra. Considering all these neurodegenerative disorders as different phenotypes of the same spectrum can help to identify common pathological pathways and consequently new therapeutic targets in these incurable diseases.
Original languageEnglish
Pages (from-to)266-275
Number of pages10
JournalBrain Pathology
Volume26
Issue number2
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Amyotrophic Lateral Sclerosis
Motor Neurons
Genes
Phenotype
Muscular Diseases
Age of Onset
Neurodegenerative Diseases
Therapeutics

Keywords

  • amyotrophic lateral sclerosis
  • distal myopathy
  • fronto temporal dementia
  • inclusion body myopathy
  • mitochondrial diseases

Cite this

Sabatelli, M., Marangi, G., Conte, A., Tasca, G., Zollino, M., & Lattante, S. (2016). New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. Brain Pathology, 26(2), 266-275. https://doi.org/10.1111/bpa.12354

New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. / Sabatelli, Mario; Marangi, Giuseppe; Conte, Amelia; Tasca, Giorgio; Zollino, Marcella; Lattante, Serena.

In: Brain Pathology, Vol. 26, No. 2, 01.03.2016, p. 266-275.

Research output: Contribution to journalArticle

Sabatelli, M, Marangi, G, Conte, A, Tasca, G, Zollino, M & Lattante, S 2016, 'New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis', Brain Pathology, vol. 26, no. 2, pp. 266-275. https://doi.org/10.1111/bpa.12354
Sabatelli, Mario ; Marangi, Giuseppe ; Conte, Amelia ; Tasca, Giorgio ; Zollino, Marcella ; Lattante, Serena. / New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. In: Brain Pathology. 2016 ; Vol. 26, No. 2. pp. 266-275.
@article{9a4b59f82570426d81792adfc23c3676,
title = "New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis",
abstract = "Amyotrophic Lateral Sclerosis (ALS) is characterized by the degeneration of upper and lower motor neurons. Clinical heterogeneity is a well-recognized feature of the disease as age of onset, site of onset and the duration of the disease can vary greatly among patients. A number of genes have been identified and associated to familial and sporadic forms of ALS but the majority of cases remains still unexplained. Recent breakthrough discoveries have demonstrated that clinical manifestations associated with ALS-related genes are not circumscribed to motor neurons involvement. In this view, ALS appears to be linked to different conditions over a continuum or spectrum in which overlapping phenotypes may be identified. In this review, we aim to examine the increasing number of spectra, including ALS/Frontotemporal Dementia and ALS/Myopathies spectra. Considering all these neurodegenerative disorders as different phenotypes of the same spectrum can help to identify common pathological pathways and consequently new therapeutic targets in these incurable diseases.",
keywords = "amyotrophic lateral sclerosis, distal myopathy, fronto temporal dementia, inclusion body myopathy, mitochondrial diseases",
author = "Mario Sabatelli and Giuseppe Marangi and Amelia Conte and Giorgio Tasca and Marcella Zollino and Serena Lattante",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/bpa.12354",
language = "English",
volume = "26",
pages = "266--275",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis

AU - Sabatelli, Mario

AU - Marangi, Giuseppe

AU - Conte, Amelia

AU - Tasca, Giorgio

AU - Zollino, Marcella

AU - Lattante, Serena

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Amyotrophic Lateral Sclerosis (ALS) is characterized by the degeneration of upper and lower motor neurons. Clinical heterogeneity is a well-recognized feature of the disease as age of onset, site of onset and the duration of the disease can vary greatly among patients. A number of genes have been identified and associated to familial and sporadic forms of ALS but the majority of cases remains still unexplained. Recent breakthrough discoveries have demonstrated that clinical manifestations associated with ALS-related genes are not circumscribed to motor neurons involvement. In this view, ALS appears to be linked to different conditions over a continuum or spectrum in which overlapping phenotypes may be identified. In this review, we aim to examine the increasing number of spectra, including ALS/Frontotemporal Dementia and ALS/Myopathies spectra. Considering all these neurodegenerative disorders as different phenotypes of the same spectrum can help to identify common pathological pathways and consequently new therapeutic targets in these incurable diseases.

AB - Amyotrophic Lateral Sclerosis (ALS) is characterized by the degeneration of upper and lower motor neurons. Clinical heterogeneity is a well-recognized feature of the disease as age of onset, site of onset and the duration of the disease can vary greatly among patients. A number of genes have been identified and associated to familial and sporadic forms of ALS but the majority of cases remains still unexplained. Recent breakthrough discoveries have demonstrated that clinical manifestations associated with ALS-related genes are not circumscribed to motor neurons involvement. In this view, ALS appears to be linked to different conditions over a continuum or spectrum in which overlapping phenotypes may be identified. In this review, we aim to examine the increasing number of spectra, including ALS/Frontotemporal Dementia and ALS/Myopathies spectra. Considering all these neurodegenerative disorders as different phenotypes of the same spectrum can help to identify common pathological pathways and consequently new therapeutic targets in these incurable diseases.

KW - amyotrophic lateral sclerosis

KW - distal myopathy

KW - fronto temporal dementia

KW - inclusion body myopathy

KW - mitochondrial diseases

U2 - 10.1111/bpa.12354

DO - 10.1111/bpa.12354

M3 - Article

VL - 26

SP - 266

EP - 275

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 2

ER -